2004
DOI: 10.1038/sj.ejcn.1602089
|View full text |Cite
|
Sign up to set email alerts
|

Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein

Abstract: Background: Achieving significant weight loss and glycemic control in diabetic patients remains a challenging task. Objective: This study compared the effects of a soy-based meal replacement (MR) plan vs an individualized diet plan (IDP; as recommended by the American Diabetes Association) on weight loss and metabolic profile. Design/Subjects: A total of 104 subjects were randomized prospectively to the two treatments for a total of 12 months. Results: In all, 77 of the 104 subjects completed the study. Percen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
121
0
3

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 128 publications
(132 citation statements)
references
References 23 publications
(29 reference statements)
8
121
0
3
Order By: Relevance
“…25 Compared with some notable positive findings, 12,14,26 our trial has observed a mild effect of soy on BW and BF% reduction, whereas this magnitude was comparable to the other two studies with the use of soy-based diet among overweight or obese patients. 13,27 However, even this mild degree of effect may have important public health implications. Evidence has indicated that even a 1-kg increase in BW .05 by comparing with placebo group by ANCOVA.…”
Section: Soy Protein and Body Composition Z-m Liu Et Almentioning
confidence: 99%
“…25 Compared with some notable positive findings, 12,14,26 our trial has observed a mild effect of soy on BW and BF% reduction, whereas this magnitude was comparable to the other two studies with the use of soy-based diet among overweight or obese patients. 13,27 However, even this mild degree of effect may have important public health implications. Evidence has indicated that even a 1-kg increase in BW .05 by comparing with placebo group by ANCOVA.…”
Section: Soy Protein and Body Composition Z-m Liu Et Almentioning
confidence: 99%
“…randomized controlled trials have reported that soya products (12) , soya protein (12)(13)(14) and soya isoflavone (14) improve glycaemic control and insulin sensitivity. However, others showed no significant effect of soya protein (27)(28)(29) and soya isoflavone (27,30,31) .…”
Section: Discussionmentioning
confidence: 99%
“…An inverse association between soya food intake and type 2 diabetes has been reported in several, but not all human studies. A diet with soyanuts (12) and supplements with soya protein, fibre, isoflavone and other soya products improved glucose homeostasis in patients with type 2 diabetes (13,14) . An inverse association between soya food intake and the prevalence of glycosuria was also reported in postmenopausal non-obese Chinese women (15) .…”
mentioning
confidence: 99%
“…A soja tem sido relacionada à redução da glicose de jejum quando consumida como parte de substituto de refeição por 3 a 12 meses (LI et al, 2005).…”
Section: -Efeito Do Consumo Daunclassified
“…Esse resultado é consistente com estudos prévios em adultos com diabetes tipo 2, que não encontraram mudança significante na insulina de jejum após consumo de 10 g de polissacarídeo da soja (TSAI et al, 1987); suplemento de soja e fibra (50 g de proteína de soja, 165 mg de isoflavona e 20 g de fibra de soja) por 6 semanas (HERMANSEN et al, 2001); e substituição baseada em soja por 3 a 12 meses (LI et al, 2005) e 40 g de proteína de soja e 88 mg de isoflavonas (GOBERT et al, 2010). No entanto, a insulina de jejum sofreu significativa redução em adultos com diabetes tipo 2 após consumo de proteína de soja (30 g de proteína e 132 mg de isoflavona) por 12 semanas (JAYAGOPAL et al, 2002).…”
Section: -Efeito Do Consumo Daunclassified